Inventor · disambiguated record
Scott Silbiger
Also filed as: SILBIGER SCOTT M · SILBIGER SCOTT MICHAEL
9 granted patents·10 pending applications·289 citations·filing 1993–2013
91Inventor score
Files withAMGEN INC15
Top patents by PatentIndex Score
19 records- 0196US7611857B2IL-receptor like molecules and uses thereofAMGEN INC·Filed 2005·Granted Nov 3, 2009·58 cites·9 claims
- 0295US7094566B2IL-17 receptor like molecules and uses thereofAMGEN INC·Filed 2001·Granted Aug 22, 2006·73 cites·26 claims
- 0393US6562596B1Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methodsAMGEN INC·Filed 1993·Granted May 13, 2003·110 cites·15 claims
- 0491US7569387B2Antibody to TNF receptor-like moleculesAMGEN INC·Filed 2006·Granted Aug 4, 2009·19 cites·15 claims
- 0587US7842788B2Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methodsAMGEN INC·Filed 2008·Granted Nov 30, 2010·6 cites·9 claims
- 0687US7435719B2Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methodsAMGEN INC·Filed 2006·Granted Oct 14, 2008·3 cites·3 claims
- 0775US7071317B2Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methodsAMGEN INC·Filed 2003·Granted Jul 4, 2006·2 cites·9 claims
- 0872US6683155B1Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methodsAMGEN INC·Filed 1996·Granted Jan 27, 2004·15 cites·17 claims
- 0969US7153669B2Nucleic acids encoding MK61 receptorsAMGEN INC·Filed 2001·Granted Dec 26, 2006·3 cites·20 claims
- 1063US2009325880A1Tnf receptor-like molecules and uses thereofAMGEN INC·Filed 2009·Application pending·0 cites
- 1162US2014037635A1Methods of treatment using il-17e antagonistsAMGEN INC·Filed 2013·Application pending·0 cites
- 1261US2007123459A1IL-17 like molecules and uses thereofAMGEN INC·Filed 2006·Application pending·0 cites
- 1358US2005048029A1Il-17 like molecules and uses thereofAMGEN INC·Filed 2004·Application pending·0 cites
- 1457US2005074427A1IL-17 like molecules and uses thereofFiled 2004·Application pending·0 cites
- 1557US2005003451A1IL-17 like molecules and uses thereofFiled 2004·Application pending·0 cites
- 1655US2011160438A1Il-17 receptor like molecules and uses thereofAMGEN INC·Filed 2010·Application pending·0 cites
- 1755US2010303820A1Methods of treatment using il-17e antagonistsAMGEN INC·Filed 2010·Application pending·0 cites
- 1849US2003124092A1IL-17 like molecules and uses thereoflike molecules and uses thereofFiled 2001·Application pending·0 cites
- 1938US2002037524A1IL-17 like molecules and uses thereofFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Scott Silbiger files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →